US6822267B1
(en)
*
|
1997-08-20 |
2004-11-23 |
Advantest Corporation |
Signal transmission circuit, CMOS semiconductor device, and circuit board
|
CA2346152A1
(en)
*
|
1998-10-16 |
2000-04-27 |
Novartis Ag |
Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors
|
AU773278B2
(en)
*
|
1998-12-14 |
2004-05-20 |
University Of Miami |
Connective tissue growth factor fragments and methods and uses thereof
|
US6518012B1
(en)
|
1999-04-02 |
2003-02-11 |
Health Research, Inc. |
Method for regulating the expression of MHC antigens and CD40 by inhibitors of histone deacetylation
|
US6449625B1
(en)
*
|
1999-04-20 |
2002-09-10 |
Lucent Technologies Inc. |
Use of a two-way stack approach to optimize flash memory management for embedded database systems
|
NZ541431A
(en)
*
|
1999-04-22 |
2008-01-31 |
Biogen Idec Inc |
Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
|
JP4509395B2
(ja)
|
1999-04-27 |
2010-07-21 |
田辺三菱製薬株式会社 |
肝臓疾患の予防治療薬
|
ATE514674T1
(de)
*
|
1999-11-23 |
2011-07-15 |
Methylgene Inc |
Inhibitoren für histone-deacetylase
|
US6544957B2
(en)
|
2000-01-04 |
2003-04-08 |
The Johns Hopkins University |
Methods and reagents for facilitating transcription
|
US7078045B2
(en)
*
|
2000-03-02 |
2006-07-18 |
Sang-Geon Kim |
Pharmaceutical composition for treatment and prevention of liver fibrosis and cirrhosis
|
CA2404915A1
(en)
*
|
2000-04-07 |
2001-10-18 |
Sang Geon Kim |
Prophylactic and therapeutic use of oltipraz as an antifibrotic and anticirrhotic agent in the liver and pharmaceutical composition containing oltipraz
|
KR20030067935A
(ko)
*
|
2002-02-09 |
2003-08-19 |
김상건 |
올티프라즈를 포함하는 간경화(간경변증) 치료를 위한 간 조직 재생용 제약 조성물
|
US7473555B2
(en)
|
2000-04-27 |
2009-01-06 |
Geron Corporation |
Protocols for making hepatocytes from embryonic stem cells
|
US7282366B2
(en)
|
2000-04-27 |
2007-10-16 |
Geron Corporation |
Hepatocytes for therapy and drug screening made from embryonic stem cells
|
US7256042B2
(en)
|
2000-04-27 |
2007-08-14 |
Geron Corporation |
Process for making hepatocytes from pluripotent stem cells
|
US6458589B1
(en)
|
2000-04-27 |
2002-10-01 |
Geron Corporation |
Hepatocyte lineage cells derived from pluripotent stem cells
|
EP1598067B1
(de)
|
2000-09-29 |
2009-05-06 |
TopoTarget UK Limited |
Carbaminsäurederivate enthaltend eine Amidgruppe zur Behandlung von Malaria
|
GB0023983D0
(en)
|
2000-09-29 |
2000-11-15 |
Prolifix Ltd |
Therapeutic compounds
|
US6888027B2
(en)
|
2000-09-29 |
2005-05-03 |
Topotarget Uk Limited |
Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors
|
AU2002243231A1
(en)
*
|
2000-11-21 |
2002-07-24 |
Wake Forest University |
Method of treating autoimmune diseases
|
DE60113645T2
(de)
*
|
2001-04-10 |
2006-07-06 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Verwendung von Histonedeacetylasehemmern zur Behandlung von Papillomaviren assoziierte Krankheiten
|
WO2002098405A1
(fr)
*
|
2001-06-05 |
2002-12-12 |
Ajinomoto Co., Inc. |
Inhibiteurs de fibrose du foie
|
WO2003033678A2
(en)
|
2001-10-18 |
2003-04-24 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Methods of using deacetylase inhibitors to promote cell differentiation and regeneration
|
AU2002351413A1
(en)
*
|
2001-12-21 |
2003-07-30 |
Patrick Bruggeman |
Method of obtaining purified enterochromaffin cells and methods of using same
|
AU2003219803B8
(en)
*
|
2002-02-15 |
2005-08-25 |
Sloan-Kettering Institute For Cancer Research |
Method of treating TRX mediated diseases
|
AU2005227400B2
(en)
*
|
2002-02-15 |
2008-04-03 |
Sloan-Kettering Institute For Cancer Research |
Method of Treating TRX Mediated Diseases
|
KR20040090978A
(ko)
|
2002-03-13 |
2004-10-27 |
얀센 파마슈티카 엔.브이. |
히스톤 디아세틸라제의 신규한 저해제로서의 설포닐-유도체
|
DK1485378T3
(da)
|
2002-03-13 |
2008-10-06 |
Janssen Pharmaceutica Nv |
Piperazinyl-, piperidinyl- og morpholinylderivater som nye inhibitorer af histondeacetylase
|
BR0307607A
(pt)
|
2002-03-13 |
2004-12-21 |
Janssen Pharmaceutica Nv |
Derivados de carbonilamino como inibidores de histona desacetilase
|
KR20040094672A
(ko)
|
2002-03-13 |
2004-11-10 |
얀센 파마슈티카 엔.브이. |
히스톤 디아세틸라제의 신규한 저해제로서의설포닐아미노-유도체
|
ES2371632T3
(es)
|
2002-03-13 |
2012-01-05 |
Janssen Pharmaceutica N.V. |
Nuevos inhibidores de desacetilasa de histona.
|
BR0308908A
(pt)
|
2002-04-03 |
2005-01-04 |
Topotarget Uk Ltd |
Composto, composição, uso de um composto, e, métodos para inibir a hdac em uma célula, para o tratamento de uma condição mediada pela hdac, de um condição proliferativa, de câncer e de psorìase
|
US8946295B2
(en)
*
|
2002-07-25 |
2015-02-03 |
Sunny Pharmtech Inc. |
Histone hyperacetylating agents for promoting wound healing and preventing scar formation
|
US6809118B2
(en)
*
|
2002-07-25 |
2004-10-26 |
Yih-Lin Chung |
Methods for therapy of radiation cutaneous syndrome
|
US8163764B2
(en)
*
|
2002-04-26 |
2012-04-24 |
Asan Laboratories Company (Cayman) Limited |
Skincare methods
|
US8846039B2
(en)
*
|
2002-04-26 |
2014-09-30 |
Asan Laboratories Company (Cayman), Limited |
Method for ameliorating pruritus
|
US8883148B2
(en)
*
|
2002-04-26 |
2014-11-11 |
Asan Laboratories Company (Cayman), Limited |
Prevention of joint destruction
|
US20060275370A1
(en)
*
|
2002-07-25 |
2006-12-07 |
Yih-Lin Chung |
Method and compositions for treatment of epithelial damage
|
EP1547617B1
(de)
*
|
2002-08-20 |
2010-04-28 |
Astellas Pharma Inc. |
Hemmer des abbaus der extrazellulären matrix von arthrodia-knorpel
|
US7154002B1
(en)
|
2002-10-08 |
2006-12-26 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
AU2004205372B2
(en)
|
2003-01-17 |
2011-02-24 |
Topotarget Uk Limited |
Hydroxamic acid compounds comprising an ester or ketone linkage as HDAC inhibitors
|
JP4790594B2
(ja)
|
2003-02-25 |
2011-10-12 |
トポターゲット ユーケー リミテッド |
Hdacインヒビターとしての、二環式ヘテロアリール基を含むヒドロキサム酸化合物
|
EP1608628A2
(de)
|
2003-03-17 |
2005-12-28 |
Takeda San Diego, Inc. |
Inhibitoren der histondeacetylase
|
US20050058611A1
(en)
*
|
2003-08-22 |
2005-03-17 |
L'oreal |
Preventing and/or combating collagen fiber degradation induced under conditions of natural exposure to sunlight
|
WO2005059167A1
(en)
*
|
2003-12-18 |
2005-06-30 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Method for identifying histone deacetylase inhibitors
|
US20050197336A1
(en)
*
|
2004-03-08 |
2005-09-08 |
Miikana Therapeutics Corporation |
Inhibitors of histone deacetylase
|
EP1574213B1
(de)
*
|
2004-03-11 |
2008-07-09 |
Asan Laboratories Company (Cayman), Limited |
Verwendung von Histone Deacetylase Hemmern zur Steigerung der therapeutischen Wirkung in der Radiotherapie und Chemotherapie
|
KR20070012380A
(ko)
*
|
2004-03-26 |
2007-01-25 |
디에스엠 아이피 어셋츠 비.브이. |
Hdac 저해제를 레티노이드와 함께 포함하는 조성물
|
US7345043B2
(en)
*
|
2004-04-01 |
2008-03-18 |
Miikana Therapeutics |
Inhibitors of histone deacetylase
|
ME01058B
(me)
|
2004-07-28 |
2012-10-20 |
Janssen Pharmaceutica Nv |
Supstituisani derivati propenil piperazina kao novi inhibitori histonske deacetilaze
|
CA2572833C
(en)
|
2004-07-28 |
2013-04-09 |
Janssen Pharmaceutica N.V. |
Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
|
WO2006066133A2
(en)
|
2004-12-16 |
2006-06-22 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
CA2594477C
(en)
|
2005-01-21 |
2016-07-12 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
EP2522396A1
(de)
|
2005-02-03 |
2012-11-14 |
TopoTarget UK Limited |
Kombinationstherapien mit HDAC-Hemmern
|
JP2008530136A
(ja)
|
2005-02-14 |
2008-08-07 |
ミイカナ セラピューティクス インコーポレイテッド |
ヒストンデアセチラーゼの阻害剤として有用な縮合複素環化合物
|
US20100087328A1
(en)
*
|
2005-03-01 |
2010-04-08 |
The Regents Of The University Of Michigan |
Brm expression and related diagnostics
|
US7604939B2
(en)
*
|
2005-03-01 |
2009-10-20 |
The Regents Of The University Of Michigan |
Methods of identifying active BRM expression-promoting HDAC inhibitors
|
US7642253B2
(en)
|
2005-05-11 |
2010-01-05 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
CA2606598C
(en)
|
2005-05-13 |
2014-12-23 |
Topotarget Uk Limited |
Pharmaceutical formulations of hdac inhibitors
|
CA2605272C
(en)
|
2005-05-18 |
2013-12-10 |
Janssen Pharmaceutica N.V. |
Substituted aminopropenyl piperidine or morpholine derivatives as novel inhibitors of histone deacetylase
|
JP2009501236A
(ja)
|
2005-07-14 |
2009-01-15 |
タケダ サン ディエゴ インコーポレイテッド |
ヒストンデアセチラーゼ阻害剤
|
US7884105B2
(en)
|
2005-10-27 |
2011-02-08 |
Janssen Pharmaceutica, N.V. |
Squaric acid derivatives as inhibitors of histone deacetylase
|
JP5377968B2
(ja)
|
2005-11-10 |
2013-12-25 |
トポターゲット ユーケー リミテッド |
癌治療のために単独で用いるまたは化学療法薬と併用するヒストンデアセチラーゼ(hdac)阻害剤
|
ATE432272T1
(de)
|
2006-01-19 |
2009-06-15 |
Janssen Pharmaceutica Nv |
Aminophenylderivate als neue inhibitoren von histondeacetylase
|
WO2007082880A1
(en)
|
2006-01-19 |
2007-07-26 |
Janssen Pharmaceutica N.V. |
Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
|
WO2007082876A1
(en)
|
2006-01-19 |
2007-07-26 |
Janssen Pharmaceutica N.V. |
Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
|
CA2635015C
(en)
|
2006-01-19 |
2014-06-03 |
Janssen Pharmaceutica N.V. |
Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
|
JP5225103B2
(ja)
|
2006-01-19 |
2013-07-03 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ヒストン・デアセチラーゼの新規なインヒビターとしてのヘテロシクリルアルキル誘導体
|
JP5247470B2
(ja)
|
2006-01-19 |
2013-07-24 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
ヒストンデアセチラーゼのインヒビターとしてのピリジン及びピリミジン誘導体
|
WO2007143117A2
(en)
|
2006-06-02 |
2007-12-13 |
Geron Corporation |
Differentiation of primate pluripotent cells to hepatocyte-lineage cells
|
WO2008044045A1
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
JP5528806B2
(ja)
|
2006-10-12 |
2014-06-25 |
アステックス、セラピューティックス、リミテッド |
複合薬剤
|
WO2009040517A2
(en)
|
2007-09-25 |
2009-04-02 |
Topotarget Uk Limited |
Methods of synthesis of certain hydroxamic acid compounds
|
US8476289B2
(en)
|
2008-03-27 |
2013-07-02 |
Janssen Pharmaceutica Nv |
Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylace
|
MD4458C1
(ro)
*
|
2014-06-19 |
2017-08-31 |
Мария ДАНУ |
Utilizarea preparatului Polibiolină în tratamentul bolnavilor cu ciroză hepatică
|
TWI794171B
(zh)
|
2016-05-11 |
2023-03-01 |
美商滬亞生物國際有限公司 |
Hdac抑制劑與pd-l1抑制劑之組合治療
|
TWI808055B
(zh)
|
2016-05-11 |
2023-07-11 |
美商滬亞生物國際有限公司 |
Hdac 抑制劑與 pd-1 抑制劑之組合治療
|